Literature DB >> 15080445

Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review.

J W Finnie1.   

Abstract

Microvascular endothelial damage by the epsilon toxin of Clostridium perfringens type D appears to be the fundamental cause of cerebral parenchymal injury and lesions occur in a seemingly dose- and time-dependent manner. Large doses of circulating toxin produce a severe, generalised, vasogenic cerebral oedema and an acute or peracute clinical course to death. With lower doses of toxin, or in partially immune sheep, focal necrosis, often bilaterally symmetrical, occurs in certain selectively vulnerable brain regions, which appear to become fewer as the toxin dose is reduced. These cases follow a more protracted clinical course, but death is the usual outcome. The precise pathogenesis of the focal brain damage found in subacutely intoxicated sheep is unresolved, but several possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15080445     DOI: 10.1111/j.1751-0813.2003.tb11474.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  21 in total

Review 1.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

2.  Clinico-pathological findings of Clostridium perfringens type D enterotoxaemia in goats and its hemolytic activity in different erythrocytes.

Authors:  A Ali Nasir; M Younus; A Rashid; S Abdul Khaliq; E Khan; S H Shah; A Aslam; M A Ghumman; M H Joiya
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

Review 3.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

4.  Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model.

Authors:  Mariano E Fernandez-Miyakawa; B Helen Jost; Stephen J Billington; Francisco A Uzal
Journal:  Vet Microbiol       Date:  2007-10-02       Impact factor: 3.293

5.  Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.

Authors:  Mariano E Fernandez-Miyakawa; Sameera Sayeed; Derek J Fisher; Rachael Poon; Vicki Adams; Julian I Rood; Bruce A McClane; Julian Saputo; Francisco A Uzal
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

6.  Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.

Authors:  J P Garcia; V Adams; J Beingesser; M L Hughes; R Poon; D Lyras; A Hill; B A McClane; J I Rood; F A Uzal
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

Review 7.  Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.

Authors:  Michel R Popoff; Bernard Poulain
Journal:  Toxins (Basel)       Date:  2010-04-15       Impact factor: 4.546

8.  The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin.

Authors:  Kareem Rashid Rumah; Yinghua Ma; Jennifer R Linden; Myat Lin Oo; Josef Anrather; Nicole Schaeren-Wiemers; Miguel A Alonso; Vincent A Fischetti; Mark S McClain; Timothy Vartanian
Journal:  PLoS Pathog       Date:  2015-05-20       Impact factor: 6.823

9.  Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats.

Authors:  Jorge Goldstein; Winston E Morris; César Fabián Loidl; Carla Tironi-Farinati; Carla Tironi-Farinatti; Bruce A McClane; Francisco A Uzal; Mariano E Fernandez Miyakawa
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

10.  Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.

Authors:  Monika Bokori-Brown; Maria C Kokkinidou; Christos G Savva; Sérgio Fernandes da Costa; Claire E Naylor; Ambrose R Cole; David S Moss; Ajit K Basak; Richard W Titball
Journal:  Protein Sci       Date:  2013-04-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.